Tissue | mRNA | Cycle of threshold (CT ± SD) | Expression ratio (relative to Ttp) (Fold) | Expression ratio (relative to liver) (Fold) |
---|---|---|---|---|
Liver | Rpl32 | 18.35 ± 0.40 | Internal control | 1.00 |
 | Ttp/Tis11/Zfp36 | 21.23 ± 0.43 | 1.00 | 1.00 |
 | Zfp36l1/Tis11b | 20.67 ± 0.54 | 1.48 | 1.00 |
 | Zfp36l2/Tis11d | 25.19 ± 0.36 | 0.06 | 1.00 |
 | Zfp36l3 | 0.00 | 0.00 |  |
 | Tnf | 39.12 ± 0.77 |  | 1.00 |
 | Csf2/Gm-csf | 0.00 |  |  |
 | Ptgs2/Cox2 | 33.09 ± 0.39 |  | 1.00 |
 | Vegfa | 20.36 ± 0.27 |  | 1.00 |
 | Vegfb | 25.69 ± 0.56 |  | 1.00 |
 | Elavl1/Hua/Hur | 22.46 ± 0.22 |  | 1.00 |
Muscle | Rpl32 | 18.26 ± 0.26 | Internal control | 1.03 |
 | Ttp/Tis11/Zfp36 | 23.81 ± 0.97 | 1.00 | 0.21 |
 | Zfp36l1/Tis11b | 24.32 ± 0.85 | 0.70 | 0.07 |
 | Zfp36l2/Tis11d | 26.51 ± 0.85 | 0.15 | 0.49 |
 | Zfp36l3 | 0.00 | 0.00 |  |
 | Tnf | 40.05 ± 0.55 |  | 0.59 |
 | Csf2/Gm-csf | 0.00 |  |  |
 | Ptgs2/Cox2 | 31.55 ± 0.83 |  | 2.42 |
 | Vegfa | 21.14 ± 0.35 |  | 0.59 |
 | Vegfb | 23.66 ± 0.29 |  | 4.27 |
 | Elavl1/Hua/Hur | 23.54 ± 0.18 |  | 0.42 |